These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 18957280)

  • 1. Glucocorticoid-induced apoptosis requires FOXO3A activity.
    Ma J; Xie Y; Shi Y; Qin W; Zhao B; Jin Y
    Biochem Biophys Res Commun; 2008 Dec; 377(3):894-8. PubMed ID: 18957280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt2 mediates glucocorticoid resistance in lymphoid malignancies through FoxO3a/Bim axis and serves as a direct target for resistance reversal.
    Xie M; Yang A; Ma J; Wu M; Xu H; Wu K; Jin Y; Xie Y
    Cell Death Dis; 2019 Jan; 9(10):1013. PubMed ID: 30598523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant microRNA-182 expression is associated with glucocorticoid resistance in lymphoblastic malignancies.
    Yang A; Ma J; Wu M; Qin W; Zhao B; Shi Y; Jin Y; Xie Y
    Leuk Lymphoma; 2012 Dec; 53(12):2465-73. PubMed ID: 22582938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against glucocorticoid-induced damage in human tenocytes by modulation of ERK, Akt, and forkhead signaling.
    Poulsen RC; Carr AJ; Hulley PA
    Endocrinology; 2011 Feb; 152(2):503-14. PubMed ID: 21209015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical Role of AMPK/FoxO3A Axis in Globular Adiponectin-Induced Cell Cycle Arrest and Apoptosis in Cancer Cells.
    Shrestha A; Nepal S; Kim MJ; Chang JH; Kim SH; Jeong GS; Jeong CH; Park GH; Jung S; Lim J; Cho E; Lee S; Park PH
    J Cell Physiol; 2016 Feb; 231(2):357-69. PubMed ID: 26089158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells.
    Wu W; Zou M; Brickley DR; Pew T; Conzen SD
    Mol Endocrinol; 2006 Oct; 20(10):2304-14. PubMed ID: 16690749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXO3a and Posttranslational Modifications Mediate Glucocorticoid Sensitivity in B-ALL.
    Consolaro F; Ghaem-Maghami S; Bortolozzi R; Zona S; Khongkow M; Basso G; Viola G; Lam EW
    Mol Cancer Res; 2015 Dec; 13(12):1578-90. PubMed ID: 26376801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2.
    Bakker WJ; Harris IS; Mak TW
    Mol Cell; 2007 Dec; 28(6):941-53. PubMed ID: 18158893
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Shen L; Lee S; Joo JC; Hong E; Cui ZY; Jo E; Park SJ; Jang HJ
    J Microbiol Biotechnol; 2022 Apr; 32(4):493-503. PubMed ID: 35283423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid (GC)-mediated down-regulation of urokinase plasminogen activator expression via the serum and GC regulated kinase-1/forkhead box O3a pathway.
    Pew T; Zou M; Brickley DR; Conzen SD
    Endocrinology; 2008 May; 149(5):2637-45. PubMed ID: 18239069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXO3a elicits a pro-apoptotic transcription program and cellular response to human lung carcinogen nicotine-derived nitrosaminoketone (NNK).
    Blake DC; Mikse OR; Freeman WM; Herzog CR
    Lung Cancer; 2010 Jan; 67(1):37-47. PubMed ID: 19380174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization.
    Kajihara T; Jones M; Fusi L; Takano M; Feroze-Zaidi F; Pirianov G; Mehmet H; Ishihara O; Higham JM; Lam EW; Brosens JJ
    Mol Endocrinol; 2006 Oct; 20(10):2444-55. PubMed ID: 16709600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor.
    Chandramohan V; Mineva ND; Burke B; Jeay S; Wu M; Shen J; Yang W; Hann SR; Sonenshein GE
    J Cell Biochem; 2008 Aug; 104(6):2091-106. PubMed ID: 18393360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression.
    Delpuech O; Griffiths B; East P; Essafi A; Lam EW; Burgering B; Downward J; Schulze A
    Mol Cell Biol; 2007 Jul; 27(13):4917-30. PubMed ID: 17452451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpain small-1 modulates Akt/FoxO3A signaling and apoptosis through PP2A.
    Bertoli C; Copetti T; Lam EW; Demarchi F; Schneider C
    Oncogene; 2009 Feb; 28(5):721-33. PubMed ID: 19029949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine protects against lidocaine-induced neurotoxicity through SIRT1 downregulation-mediated activation of FOXO3a.
    Zheng LN; Guo FQ; Li ZS; Wang Z; Ma JH; Wang T; Wei JF; Zhang WW
    Hum Exp Toxicol; 2020 Sep; 39(9):1213-1223. PubMed ID: 32228195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation-mediated downregulation of lncRNA PVT1 promotes granulosa cell apoptosis in premature ovarian insufficiency via interacting with Foxo3a.
    Wang F; Chen X; Sun B; Ma Y; Niu W; Zhai J; Sun Y
    J Cell Physiol; 2021 Jul; 236(7):5162-5175. PubMed ID: 33393111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dok-5 is involved in cardiomyocyte differentiation through PKB/FOXO3a pathway.
    Wen J; Xia Q; Wang C; Liu W; Chen Y; Gao J; Gong Y; Yin B; Ke Y; Qiang B; Yuan J; Peng X
    J Mol Cell Cardiol; 2009 Dec; 47(6):761-9. PubMed ID: 19800350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection.
    van Grevenynghe J; Procopio FA; He Z; Chomont N; Riou C; Zhang Y; Gimmig S; Boucher G; Wilkinson P; Shi Y; Yassine-Diab B; Said EA; Trautmann L; El Far M; Balderas RS; Boulassel MR; Routy JP; Haddad EK; Sekaly RP
    Nat Med; 2008 Mar; 14(3):266-74. PubMed ID: 18311149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization.
    Potente M; Urbich C; Sasaki K; Hofmann WK; Heeschen C; Aicher A; Kollipara R; DePinho RA; Zeiher AM; Dimmeler S
    J Clin Invest; 2005 Sep; 115(9):2382-92. PubMed ID: 16100571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.